Sanofi to Buy Origimm Biotechnology for Acne Vaccine Candidate

PARIS — French healthcare company Sanofi said on Wednesday it would buy Austrian group Origimm Biotechnology, a move that will add a potential first-in-class vaccine candidate to treat acne to its pipeline. Read More